BridgeBio announced that the Palo Alto, Calif.-based biopharmaceutical company signed an exclusive deal with Bristol Myers Squibb to develop and commercialize a potential treatment for cancer.

EVERSANA, the pioneer of next-generation commercial services to the global life sciences industry, and Vector Pharma FZCO of Dubai UAE, the leading full-service distributor for rare disease, oncology and highly specialized therapeutics in the Middle East, North Africa and Turkish markets, announced a strategic partnership to expand services across the Middle East and North African markets.

Eversana

EVERSANA, a pioneer of next generation commercial services to the global life sciences industry, opened a new office in the heart of London’s Holborn district to serve the company’s growing client and team needs.

EVERSANA, a pioneer of next-generation commercial services to the global life sciences industry, announced a strategic partnership with Integra Connect LLC designed to support life sciences companies as they develop and commercialize new oncology treatments.

Evoke Pharma Inc., a specialty pharmaceutical company primarily focused on treatments for gastrointestinal (GI) diseases, and EVERSANA Life Science Service LLC, an independent provider of global commercial services to the life science industry, announced an extension of their agreement. The companies will continue collaborating on the commercialization and distribution of Gimoti (metoclopramide) nasal spray in the United States through the end of 2026.

CGT supply chain mastery starts with a clear understanding of the patient journey and product journey and how these two journeys diverge from processes companies have established to support other modalities.

Seres Therapeutics and Nestlé Health Science have teamed up for the joint commercialization of Seres’ investigational oral microbiome treatment for recurrent Clostridioides difficile (C. difficile) infections. 

Ashfield Engage, part of UDG Healthcare plc, today announced that it has been selected by U.S.-based Pacira BioSciences Inc. to provide strategic commercialization services for the company’s non-opioid pain management products in select European countries. Pacira has partnered with Ashfield Engage to develop a commercial strategy and deliver outsourced operations in numerous European countries, including the UK, Germany, Sweden, Austria, the Netherlands and Finland.

Fingerpaint, a full-service health and wellness marketing agency, executed a strategic investment in Leaderboard Branding, a leading global naming and branding business headquartered in Charlotte, N.C., to grow its portfolio of companies.

MacroGenics Inc. announced a partnership with Eversana to commercialize margetuximab in the United States, if approved.